Login / Signup

Development and Characterization of a Luminescence-Based High-Throughput Serum Bactericidal Assay (L-SBA) to Assess Bactericidal Activity of Human Sera against Nontyphoidal Salmonella .

Maria Grazia ArutaDaniele De SimoneHelen DaleEsmelda ChirwaInnocent KadwalaMaurice MbeweHappy BandaMelita GordonMariagrazia PizzaFrancesco Berlanda ScorzaTonney NyirendaRocío CanalsOmar Rossinull On Behalf Of The Vacc-iNTS Consortium Collaborators
Published in: Methods and protocols (2022)
Salmonella Typhimurium and Salmonella Enteritidis are leading causative agents of invasive nontyphoidal Salmonella (iNTS) disease, which represents one of the major causes of death and morbidity in sub-Saharan Africa, still partially underestimated. Large sero-epidemiological studies are necessary to unravel the burden of disease and guide the introduction of vaccines that are not yet available. Even if no correlate of protection has been determined so far for iNTS, the evaluation of complement-mediated functionality of antibodies generated towards natural infection or elicited upon vaccination may represent a big step towards this achievement. Here we present the setup and the intra-laboratory characterization in terms of repeatability, intermediate precision, linearity, and specificity of a high-throughput luminescence-based serum bactericidal assay (L-SBA). This method could be useful to perform sero-epidemiological studies across iNTS endemic countries and for evaluation of antibodies raised against iNTS vaccine candidates in upcoming clinical trials.
Keyphrases
  • high throughput
  • listeria monocytogenes
  • escherichia coli
  • clinical trial
  • single cell
  • endothelial cells
  • quantum dots
  • case control
  • deep learning
  • pluripotent stem cells
  • study protocol